A new therapeutic option for facial seborrhoeic dermatitis: Indole-3-acetic acid photodynamic therapy

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue 1, 2014, Pages 94-99

  Kwon, S H ^a   Jeong, M Y ^a   Park, K C ^a   Youn, S W ^a   Huh, C H ^a   Na, J I ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AC GEL; INDOLEACETIC ACID; UNCLASSIFIED DRUG;

ADULT; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; DESQUAMATION; DIODE; DRUG SAFETY; DRUG TOLERANCE; FACE ERYTHEMA; FACIAL SEBORRHOEIC DERMATITIS; FEMALE; HUMAN; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT ASSESSMENT; PHOTODYNAMIC THERAPY; PHOTODYNAMIC THERAPY DEVICE; POSTINFLAMMATORY HYPERPIGMENTATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; SCAR FORMATION; SEBORRHEIC DERMATITIS; SEBORRHOEIC DERMATITIS AREA AND SEVERITY INDEX; SEBUM PRODUCTION METER; SEBUM SECRETION; SINGLE BLIND PROCEDURE; SKIN BURNING SENSATION; SKIN PAIN; SKIN SWELLING; SKIN TIGHTNESS; YOUNG ADULT;

DERMATITIS, SEBORRHEIC; FACE; HUMANS; INDOLEACETIC ACIDS; PHOTOCHEMOTHERAPY; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 84890555594     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12070     Document Type: Article

References (23)

1. Hay RJ, Graham-Brown RA,. Dandruff and seborrhoeic dermatitis: causes and management. Clin Exp Dermatol 1997; 22: 3-6.
2. Johnson MT, Roberts J,. Skin conditions and related need for medical care among persons 1-74 years. United States, 1971-1974. Vital Health Stat 11 1978; 212: 1-72.
3. Naldi L, Rebora A,. Clinical practice. Seborrheic dermatitis. N Engl J Med 2009; 360: 387-396.
4. DeAngelis YM, Gemmer CM, Kaczvinsky JR, Kenneally DC, Schwartz JR, Dawson TL Jr,. Three etiologic facets of dandruff and seborrheic dermatitis: Malassezia fungi, sebaceous lipids, and individual sensitivity. J Investig Dermatol Symp Proc 2005; 10: 295-297.
5. Thomas DS, Ingham E, Bojar RA, Holland KT,. In vitro modulation of human keratinocyte pro- and anti-inflammatory cytokine production by the capsule of Malassezia species. FEMS Immunol Med Microbiol 2008; 54: 203-214.
6. Green CA, Farr PM, Shuster S,. Treatment of seborrhoeic dermatitis with ketoconazole: II. Response of seborrhoeic dermatitis of the face, scalp and trunk to topical ketoconazole. Br J Dermatol 1987; 116: 217-221.
7. Elewski BE, Abramovits W, Kempers S, et al. A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions. J Drugs Dermatol 2007; 6: 1001-1008.
8. Warshaw EM, Wohlhuter RJ, Liu A, et al. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis. J Am Acad Dermatol 2007; 57: 257-264.
9. Cook BA, Warshaw EM,. Role of topical calcineurin inhibitors in the treatment of seborrheic dermatitis: a review of pathophysiology, safety, and efficacy. Am J Clin Dermatol 2009; 10: 103-118.
10. Koc E, Arca E, Kose O, Akar A,. An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis. J Dermatolog Treat 2009; 20: 4-9.
11. Na JI, Kim SY, Kim JH, Youn SW, Huh CH, Park KC,. Indole-3-acetic acid: a potential new photosensitizer for photodynamic therapy of acne vulgaris. Lasers Surg Med 2011; 43: 200-205.
12. Armer RE, Ashton MR, Boyd EA, et al. Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2. J Med Chem 2005; 48: 6174-6177.
13. Choi JW, Kwon IH, Youn JI,. High-concentration (20 mug g(-)(1)) tacalcitol ointment in the treatment of facial psoriasis: an 8-week open-label clinical trial. Br J Dermatol 2010; 162: 1359-1364.
14. Folkes LK, Wardman P,. Enhancing the efficacy of photodynamic cancer therapy by radicals from plant auxin (indole-3-acetic acid). Cancer Res 2003; 63: 776-779.
15. Wardman P,. Indole-3-acetic acids and horseradish peroxidase: a new prodrug/enzyme combination for targeted cancer therapy. Curr Pharm Des 2002; 8: 1363-1374.
16. Kim DS, Kim SY, Jeong YM, et al. Light-activated indole-3-acetic acid induces apoptosis in g361 human melanoma cells. Biol Pharm Bull 2006; 29: 2404-2409.
17. Park KC, Kim SY, Kim DS,. Experimental photodynamic therapy for liver cancer cell-implanted nude mice by an indole-3-acetic acid and intense pulsed light combination. Biol Pharm Bull 2009; 32: 1609-1613.
18. Huh SY, Na JI, Huh CH, Park KC,. The effect of photodynamic therapy using indole-3-acetic Acid and green light on acne vulgaris. Ann Dermatol 2012; 24: 56-60.
19. Iinuma K, Sato T, Akimoto N, et al. Involvement of Propionibacterium acnes in the augmentation of lipogenesis in hamster sebaceous glands in vivo and in vitro. J Invest Dermatol 2009; 129: 2113-2119.
20. Papp KA, Papp A, Dahmer B, Clark CS,. Single-blind, randomized controlled trial evaluating the treatment of facial seborrheic dermatitis with hydrocortisone 1% ointment compared with tacrolimus 0.1% ointment in adults. J Am Acad Dermatol 2012; 67: e11-15.
21. Hongcharu W, Taylor CR, Chang Y, Aghassi D, Suthamjariya K, Anderson RR,. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000; 115: 183-192.
22. Juzeniene A, Juzenas P, Ma LW, Iani V, Moan J,. Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin. Br J Dermatol 2006; 155: 791-799.
23. Moseley H, Ibbotson S, Woods J, et al. Clinical and research applications of photodynamic therapy in dermatology: experience of the Scottish PDT Centre. Lasers Surg Med 2006; 38: 403-416.